BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17988345)

  • 1. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau.
    Adişen E; Oztaş M; Gürer MA
    Int J Dermatol; 2007 Nov; 46(11):1205-7. PubMed ID: 17988345
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept responsive acrodermatitis continua of Hallopeau: is a pattern developing?
    Bonish B; Rashid RM; Swan J
    J Drugs Dermatol; 2006 Oct; 5(9):903-4. PubMed ID: 17039659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
    Nikkels AF; Piérard GE
    J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
    Thielen AM; Barde C; Marazza G; Saurat JH
    Dermatology; 2008; 217(2):137-9. PubMed ID: 18503258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
    Kazinski K; Joyce KM; Hodson D
    J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau.
    Weisshaar E; Diepgen TL
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):489-92. PubMed ID: 17537042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrodermatitis continua resistant to etanercept: therapeutic challenge and unfortunate outcome.
    Gokdemir G; Kutlu S; Köşlü A
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):345-7. PubMed ID: 18554224
    [No Abstract]   [Full Text] [Related]  

  • 8. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
    Silpa-archa N; Wongpraparut C
    J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
    Juan A; Ribas B; Nadal C; Ros I
    J Rheumatol; 2005 Oct; 32(10):2061; author reply 2061-2. PubMed ID: 16206372
    [No Abstract]   [Full Text] [Related]  

  • 10. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
    Safa G; Loppin M; Bousser AM; Barbarot S
    J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S19-20. PubMed ID: 17097376
    [No Abstract]   [Full Text] [Related]  

  • 11. [Etanercept. Other indications].
    Hernanz JM
    Actas Dermosifiliogr; 2010 May; 101 Suppl 1():111-6. PubMed ID: 20492891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept for the treatment of hidradenitis suppurativa.
    Sotiriou E; Apalla Z; Ioannidos D
    Acta Derm Venereol; 2009; 89(1):82-3. PubMed ID: 19197548
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
    Moutsopoulos NM; Katsifis GE; Angelov N; Leakan RA; Sankar V; Pillemer S; Wahl SM
    Ann Rheum Dis; 2008 Oct; 67(10):1437-43. PubMed ID: 18198195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept.
    Zeichner JA; Stern DW; Lebwohl M
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S120-1. PubMed ID: 16488322
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure of etanercept therapy in disseminated granuloma annulare.
    Kreuter A; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1236-7; author reply 1237. PubMed ID: 16983020
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the QuantiFERON-TB Gold test as screening prior to administration of tumor necrosis factor inhibitors.
    Martinez LC; Harrison-Balestra C; Caeiro JP; Nousari CH
    Arch Dermatol; 2007 Jun; 143(6):809-10. PubMed ID: 17576961
    [No Abstract]   [Full Text] [Related]  

  • 18. A pilot study of etanercept treatment for pemphigus vulgaris.
    Fiorentino DF; Garcia MS; Rehmus W; Kimball AB
    Arch Dermatol; 2011 Jan; 147(1):117-8. PubMed ID: 21242406
    [No Abstract]   [Full Text] [Related]  

  • 19. Perispinal etanercept for neuroinflammatory disorders.
    Tobinick E
    Drug Discov Today; 2009 Feb; 14(3-4):168-77. PubMed ID: 19027875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of etanercept and other tumor necrosis factor-alpha blockers in infertility: it's time to get serious.
    Wallace DJ
    J Rheumatol; 2003 Sep; 30(9):1897-9. PubMed ID: 12966586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.